Insights on expert networks, market research, UX research, and AI training from the CleverX team.
When concept testing under deadline, AI-moderated interviews cut study time from weeks to days. Here is how speed, accuracy and cost actually compare to live sessions.
C-suite interviews fail most often at the calendar stage. AI moderation eliminates that bottleneck and lets executives participate on their own schedule, without a live researcher in the room.
Researchers worry that AI moderation flattens pricing responses. The evidence points the other way: participants disclose more about price sensitivity when a human is not in the room.
Win/loss programs fail when reps run their own interviews. Here is how AI moderation removes bias and lets you run 10x more conversations per quarter.
B2B panel pricing often shocks first-time buyers. Here is what drives the gap over consumer panels and how to know when paying it is justified.
Most B2B research projects stall because teams underestimate how long recruitment actually takes. Here are the realistic timelines by audience type, channel, and study format.
Before you sign with a B2B panel provider, these are the exact questions that separate credible vendors from ones that will waste your budget on bad data.
Running 50 to 200 UX interviews in a sprint used to be impossible. These platforms changed that. Here is how to pick the right one for your team.
Desk research gives you a TAM estimate. Primary research with real segments tells you whether that estimate is real. Here is how to choose the right platform.
Not all research platforms handle pricing studies equally. Here is how to match your pricing method to the right tool and recruit real buyers who actually hold budget.
When no analyst report covers your category, you create the evidence yourself. Here is the research playbook founders and PMs use to prove a new market exists before launch.
Choosing the wrong incentive format costs you participants before the study begins. Here is how cash and gift cards compare on participation rates, cost per completion, and no-show risk across study types.